Synthesis and drug delivery of mesoporous silica nanoparticles for cancer therapy

In the past decade, mesoporous silica nanoparticles (MSNs) have attracted more and more attention for their potential biomedical applications. With their high surface area and tailored mesoporous structure, MSNs as drug delivery systems (DDSs) show significant advantages over traditional drug nanocarriers. In this review, we discuss the progress in the synthesis and drug delivery of mesoporous silica nanoparticles for cancer therapy. The review also explains their multifunctional counterparts as drug carriers and the prominent achievements using mesoporous silica nanoparticles in drug delivery.